Joshua Muia: Our Latest Review on the Proatherogenic Metalloprotease ADAMTS7
Joshua Muia, Associate Investigator at Versiti Blood Research Institute, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Thrilled to share our newly published review on the proatherogenic metalloprotease ADAMTS7!
Proud of the incredible effort by trainees in my lab, working together with medical students and postdoctoral fellows across Oklahoma State University Center for Health Sciences, National Eye Institute (NIH), Georgetown University Medical Center, and Versiti Blood Research Institute.”
Title: The biology and pathophysiology of the proatherogenic metalloprotease ADAMTS7
Authors: Shiwali Goyal, James Muniu, Mohd Akbar Bhat, Eli Oldham, Derrick Pruitt, Luis Frias Perez, Frida Miranda, Joshua Muia
Read the Full Article on Open Biology
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 30, 2026, 13:03Amira Mohy: Diagnostic Flow Cytometry Panels for Hematological Malignancies
-
Sep 30, 2026, 12:52Paul Watton: Could Repetitive Head Impacts Leave a Molecular Memory?
-
Sep 30, 2026, 12:41The Journey to ISTH 2027 Starts in Vancouver
-
Sep 30, 2026, 11:36Basit Ali: A Closer Look at CT Venography
-
Sep 30, 2026, 11:16Christina Pohlman: Could aPL Levels Help Predict Stroke Recurrence?
-
Sep 30, 2026, 10:55Rana Al Hrout: Diagnostic Approach to Hypochromic Microcytic Anemia
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate